866-997-4948(US-Canada Toll Free)

Published on : Jun 20, 2016

Globally the incidence of cardiovascular ailments has risen at an alarming level. The rising prevalence of obesity and sedentary lifestyle have further bolstered the spread of heart diseases, thus giving impetus to the global intravascular ultrasound (IVUS) devices market. 

Intravascular ultrasound is conducted to see inside blood vessels. It uses sound waves for diagnosis. Intravascular ultrasound is a medical imaging methodology that is carried out to examine coronary blood arteries. IVUS devices are uniquely designed catheters with a miniaturized probe attached to their distal end and a computerized equipment attached to their proximal end. These devices assist in the application of ultrasound technology to capture accurate images of blood vessels through blood columns surrounding them. 

Increasing Incidence of Coronary Heart Diseases to Boost Global Intravascular Ultrasound Devices Market

The demand for IVUS devices mainly arises to obtained images of coronary arteries to study the amount of artheromatous plaque deposited at any point in epicardial coronary artery. Such plaque built up in epicardial coronary artery can prove fatal for patients since it obstructs the blood blow, thereby disturbing their normal blood pressure and ultimately augmenting patients’ heart complications. 

Due to its functionalities IVUS is considered a valuable adjunct to angioplasty because it ensures precise diagnosis and effective treatment of coronary diseases. According to the WHO, over 17.3 million people have died around the world in 2008 from CVD. This represents about 30% of the deaths globally. Such increasing incidence of cardiovascular disease will bolster the global intravascular ultrasound devices market. 

Asia Pacific Dominates Global Intravascular Ultrasound Devices Market

Regionally, Asia Pacific held the largest share in the global intravascular ultrasound devices market. Japan accounts for the largest share in the region market. The growth witnessed by the IVUS devices market in Japan is mainly aided by the favorable reimbursement policies in the nation. North America presently holds the second-largest in the global market. The rising prevalence of heart diseases and obesity in the U.S. is primarily aiding the expansion of the IVUS devices market in the region. Europe however has exhibited meager prospects for the market due to the absence of proper reimbursement policies in the region.